Suggested baseline investigations for anemia in patients with cancer receiving chemotherapy
| Suggested investigation . |
|---|
| Thorough drug exposure history |
| Review of a peripheral blood smear* |
| Analyses, where indicated, for iron, total iron-binding capacity, transferrin saturation, ferritin, folate, vitamin B12, or hemoglobinopathy screening |
| Assessment of reticulocyte count, occult blood loss, and renal Insufficiency |
| Baseline erythropoietin level |
| Testing of serum thyroid-stimulating hormone level, where indicated |
| Investigations may also include direct antiglobulin testing (eg, Coombs test) for patients with chronic lymphocytic leukemia, non-Hodgkin lymphoma, or a history of autoimmune disease |
| Suggested investigation . |
|---|
| Thorough drug exposure history |
| Review of a peripheral blood smear* |
| Analyses, where indicated, for iron, total iron-binding capacity, transferrin saturation, ferritin, folate, vitamin B12, or hemoglobinopathy screening |
| Assessment of reticulocyte count, occult blood loss, and renal Insufficiency |
| Baseline erythropoietin level |
| Testing of serum thyroid-stimulating hormone level, where indicated |
| Investigations may also include direct antiglobulin testing (eg, Coombs test) for patients with chronic lymphocytic leukemia, non-Hodgkin lymphoma, or a history of autoimmune disease |
Suggestions are based on the consensus of the Expert Panel. This is not intended to be a comprehensive list of investigations.
And in some cases, a bone marrow examination.